For US Residents Only | Visit Health Care Professionals Site
Image: Sanofi Pasteur Logo

then we've got a flu vaccine specially formulated for you.1

Image: If you remember when rock was young, then we have a flu vaccine specially formulated for you.
Image: Find Fluzone Vaccines Near You

Search by Practice or Pharmacy

Search by practice or pharmacy (optional)

Find it now

Ask your health care provider about Fluzone
Intradermal Quadrivalent vaccine or Fluzone High-Dose vaccine.

then we've got a flu vaccine specially formulated for you.1

Image: If you remember when rock was young, then we have a flu vaccine specially formulated for you. Image: The first and only flu vaccine for people 65+

The first flu vaccine specially formulated for people 65 years and older.1

As you get older, your immune system weakens.2,3 Therefore, you don't have as high an antibody response after receiving the traditional flu vaccine to help your body fight off the flu.3,4 Fluzone High-Dose vaccine is made for people 65+ to help promote a stronger immune response to the flu than a regular flu shot.1,5

Proven to protect against the flu better than our regular flu shot.

Fluzone High-Dose vaccine is significantly more effective than Fluzone vaccine in preventing the flu — 24.2% more effective.*1 It has 4 times the antigen of a regular flu shot for a stronger immune response to the flu.1 This helps protect those 65+ from the flu and the dangerous complications that can come with it.1,6

Image: 24 % more effective than Fluzone vaccine
* In a clinical study, Fluzone High-Dose vaccine was 24.2% more effective than Fluzone vaccine in preventing laboratory-confirmed influenza.

Flu complications can be especially devastating when you're 65 or older. 6-8

Up to 90% of flu-related deaths 6,9 and 60% of flu-related hospitalizations in the U.S. occur in people 65 or older.7,8 That's why it's important to take extra precautions to help protect yourself.

So what can you do? Get vaccinated.1,3 It's the best way to help protect yourself from the flu virus and its complications. It's also helpful to take preventive measures10,11 such as:

  • Encouraging others to cover coughs and sneezes

  • Washing hands

  • Staying away from people who are sick

Medicare coverage for the Fluzone High-Dose vaccine.

Fluzone High-Dose vaccine may be covered with no co-payment or deductible under Medicare, Medicare Advantage, and private insurance policies.13

Common side effects of Fluzone High-Dose vaccine.

Fluzone High-Dose vaccine is given by an injection (shot) in the arm.1 You may have pain, swelling, and redness at the injection site; fever; headache; fatigue; and muscle aches.1 Other side effects may occur and usually disappear within a few days.1 If they don't, please contact your doctor.

There are different types of flu. 6,14 Fluzone High-Dose vaccine helps protect against the flu virus strains (subtypes A and type B) contained in the vaccine; however, vaccination with Fluzone High-Dose vaccine may not protect all individuals.1

Get Fluzone High-Dose vaccine.

Ask for the high-dose flu shot. Find it Now

Where can I get Fluzone High-Dose vaccine?

Find it Now

CDC Influenza Alert

The 2014-2015 flu season was severe for people 65 years and older, with very high hospitalization rates being recorded.7

There’s a Fluzone vaccine for you.

Important Safety Information

Indication

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine.

Fluzone Quadrivalent vaccine is given to people 6 months of age and older. Fluzone Intradermal Quadrivalent vaccine is given to people 18 through 64 years of age. Fluzone High-Dose vaccine is given to people 65 years of age and older.

Safety Information

Side effects to Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines include pain and swelling at the injection site (also itching in adults receiving Fluzone Intradermal Quadrivalent vaccine); muscle aches, fatigue, headache, and fever (also irritability, abnormal crying, drowsiness, appetite loss, and vomiting in young children receiving Fluzone Quadrivalent vaccine). Itching, redness, swelling, and firmness at the injection site occurred more frequently with Fluzone Intradermal vaccine (containing 3 influenza strains) than with Fluzone vaccine. Other side effects may occur.

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose, vaccines should not be administered to anyone with a severe allergic reaction (eg, anaphylaxis) to any vaccine component, including eggs, egg products, or thimerosal (the multidose vial is the only presentation containing thimerosal), or to a previous dose of any influenza vaccine.

Tell the doctor if you/your child has ever experienced Guillain-Barré syndrome (severe muscle weakness) after a previous dose of influenza vaccine. If you notice any other problems or symptoms following vaccination, please contact your health care professional immediately. Vaccination with Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine may not protect all individuals.

For more information about Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, or Fluzone High-Dose vaccine, talk to your health care professional and see complete Patient Information.

References

  1. Fluzone High-Dose vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2015.
  2. Aspinall R, Del Giudice G, Effros RB, Grubeck-Loebenstein B, Sambhara S. Challenges for vaccination in the elderly. Immun Ageing. 2007;4:9.
  3. Monto AS, Ansaldi F, Aspinall R, et al. Influenza control in the 21st century: optimizing protection of older adults. Vaccine. 2009;27(37):5043–5053.
  4. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24(8):1159–1169.
  5. Centers for Disease Control and Prevention. Licensure of a high-dose inactivated influenza vaccine for persons aged ≥65 years (Fluzone High-Dose) and guidance for use — United States, 2010. MMWR. 2010;59(16):485–486.
  6. Hamborsky J, Kroger A, Wolfe C. Influenza. In: Hamborsky J, Kroger A, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). 13th ed. Washington, DC: Public Health Foundation; 2015:187–208.
  7. Appiah GD, Blanton L, D'Mello T, et al. Influenza activity — United States, 2014−15 season and composition of the 2015–16 influenza vaccine. MMWR. 2015;64(21):583–590.
  8. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333–1340.
  9. CDC. Estimates of deaths associated with seasonal influenza—United States, 1976-2007. MMWR. 2010;59(33):1057–1062.
  10. World Health Organization (WHO) Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis. 2006;12(1):88–94
  11. CDC. Prevention and Control of Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2010;59(RR08):1–62.
  12. Grohskopf LA, Olsen SJ, Sokolow LZ, et al. Prevention and Control of Influenza with Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014-15 Influenza Season. MMWR. 2014;63(32):691–698
  13. Center for Medicare and Medicaid Services (CMMS). 2012-2013 Immunizers’ Question and Answer Guide to Medicare Part B, Medicaid and CHIP Coverage of Seasonal Influenza and Pneumococcal Vaccinations. Baltimore, MD: Center for Medicare and Medicaid Services; 2012.
  14. Treanor JJ. Influenza viruses, including avian influenza and swine influenza. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010:2265–2288
  15. CDC. Recommended adult immunization schedule: United States - 2015. http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf. Accessed June 10, 2015.

PLEASE NOTE

By clicking on this link, you will be leaving this Sanofi Pasteur website and going to another, entirely independent website. Sanofi Pasteur provides this link as a service to its website visitors; however, it takes no responsibility for the information presented on any website but its own.

This link has opened in a new window. To return to your original site, please close this new window.

Click here to go to the page you requested. Click here to close this window and return to the site.